Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin.

Liu, Yi; Sukumar, Uday K; Kanada, Masamitsu; Krishnan, Anandi; Massoud, Tarik F; Paulmurugan, Ramasamy

Liu, Yi; Sukumar, Uday K; Kanada, Masamitsu; Krishnan, Anandi; Massoud, Tarik F; Paulmurugan, Ramasamy.

Liu Y; Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California.
Sukumar UK; Department of Critical Care Medicine, Chongqing Medical University Affiliated Second Hospital, Chongqing, China.
Kanada M; Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California.
Krishnan A; Institute for Quantitative Health Science and Engineering (IQ), Michigan State University, East Lansing, MI 48824., USA.
Massoud TF; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Paulmurugan R; Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California.

Adv Funct Mater ; 31(41)2021 Oct 08.

Article en En | MEDLINE | ID: mdl-34899115